National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 3) (PB 26 of 2019) (Cth)

Case

PB 26 of 2019

National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 3)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated         27   March 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

  1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 3).

(2)This Instrument may also be cited as PB 26 of 2019.

  1. Commencement

This Instrument commences on 1 April 2019.

  1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

  1. Schedule 1, after entry for Diphenoxylate with Atropine

insert:

Dipyridamole with aspirin Capsule 200 mg (sustained release)- 25 mg Oral Asasantin SR 60 20.91 28.41
  1. Schedule 1, entry for Levonorgestrel with Ethinylestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets [Brand: Levlen ED]

omit from the column headed “Claimed Price”:   8.71        substitute:                8.94

  1. Schedule 1, entry for Levonorgestrel with Ethinylestradiol in the form Pack containing 6 tablets 50 micrograms- 30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets [Brand: Triquilar ED]

omit from the column headed “Claimed Price”:   17.79      substitute:                19.79

  1. Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)

omit from the column headed “Determined  Price”:                 3.45        substitute:                3.90

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0